Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended April 30, 2026
Business Overview: The Company designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure. A significant strategic development was the acquisition of Nu Aire, Inc. in November 2024, which expanded the product portfolio to include biological safety cabinets, CO2 incubators, and ultralow freezers. Operations are divided into two segments: Lab Products Group (LPG) and International.
Key Financial Metrics
| Metric | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Net Sales | $282.0 million | $240.5 million |
| Gross Profit | $80.4 million | $68.9 million |
| Gross Margin | 28.5% | 28.6% |
| Operating Earnings | $16.7 million | $17.8 million |
| Net Earnings (Attributable to Kewaunee) | $9.6 million | $11.4 million |
| Diluted EPS | $3.22 | $3.83 |
| Operating Cash Flow | $18.6 million | $14.8 million |
| Order Backlog (April 30) | $165.9 million | $214.6 million |
| Total Debt (Term Loans) | $20.1 million | $37.7 million (incl. Seller Notes) |
| Working Capital | $57.0 million | $64.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17.3% to $282.0 million, driven primarily by the inclusion of Nu Aire in the LPG segment (LPG sales up 19.8%). International sales grew 9.9% due to the delivery of previously delayed projects in India.
- Profitability Decline: Net earnings decreased 15.7% to $9.6 million. This decline was attributed to increased operating expenses ($63.7M vs $51.1M) related to the Nu Aire acquisition, higher interest expense due to full-year debt service on acquisition financing, and a higher effective tax rate (23.8% vs 21.7%).
- Backlog Reduction: Order backlog decreased 22.7% to $165.9 million, with the International segment backlog dropping significantly from $90.7 million to $47.1 million.
- Debt Restructuring: The Company repaid $23.0 million in subordinated seller notes related to the Nu Aire acquisition in December 2025. Total long-term debt decreased as seller notes were extinguished, though term loan balances remained to fund the acquisition.
Outlook, Risks, and Management Commentary
- Outlook: Management remains focused on disciplined capital allocation and operational execution. Fiscal 2027 capital expenditures are anticipated to be approximately $6.0 million, funded by operating activities and the revolving credit facility.
- Acquisition Integration: The Company is integrating Nu Aire to improve performance as life sciences market conditions recover. The acquisition expanded distribution partners in regions where Kewaunee previously had no presence.
- Risks:
- Customer Concentration: Two domestic dealers and a national distributor accounted for 34% of sales in 2026.
- Supply Chain & Costs: Exposure to raw material price fluctuations (steel, wood, epoxy resin) and potential supply disruptions.
- International Exposure: 28% of revenues are derived from international sales, exposing the company to foreign currency fluctuations and geopolitical risks.
- Construction Delays: Revenue recognition is often delayed due to customer construction schedules and retention amounts held until project completion.
- Unusual Items: Other income increased to $0.9 million due to the acceleration of deferred financing costs related to the payoff of a previous credit facility and fixed asset disposals.
Investor Verification Checklist
- Backlog Quality: Verify the composition of the $165.9 million backlog and the likelihood of shipment delays given the 22% year-over-year decline.
- Acquisition Synergies: Assess the progress of Nu Aire integration and whether the anticipated cost savings and revenue synergies are materializing to offset increased operating expenses.
- Debt Covenants: Confirm continued compliance with the PNC Loan Agreement covenants (Senior Debt/EBITDA < 2.50x; Fixed Charge Coverage > 1.20x).
- Customer Concentration: Monitor the stability of the top three channel partners representing 34% of total sales.
- Working Capital Trends: Analyze the $7.7 million decrease in working capital and the impact of decreased accounts payable and accrued expenses on future liquidity.